Design Therapeutics, Inc.
DSGN
Revenue
33.00k
▲13.00k▲65.00%
3 Months ChangeAssets
269.58M
▼-9.21M▼-3.30%
3 Months ChangeLiabilities
8.34M
▼-896.00k▼-9.70%
3 Months ChangeFree Cash Flow
-12.63M
▲4.88M▲27.85%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-05
Form 10-Q
ID: 0000950170-24-090337
2024-08-05
Form 8-K
ID: 0000950170-24-090332
2024-06-17
Form 8-K
ID: 0000950170-24-074243
2024-05-08
Form 10-Q
ID: 0000950170-24-055788
2024-05-08
Form 8-K
ID: 0000950170-24-055645
2024-03-19
Form 8-K
ID: 0000950170-24-033475
2023-11-13
Form 10-Q
ID: 0000950170-23-062958
2023-11-13
Form 8-K
ID: 0000950170-23-062937
2023-08-25
Form 8-K
ID: 0001193125-23-221586
2023-08-14
Form 10-Q
ID: 0000950170-23-042411